Teprenone (or geranylgeranylacetone), sold under the brand name Selbex,[1] is a medication used for the treatment of gastric ulcers.[2]
Clinical data | |
---|---|
Trade names | Selbex |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H38O |
Molar mass | 330.556 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
References
edit- ^ Liu X, Jia B, Lin S (January 1996). "[Teprenone in the treatment of chronic superficial gastritis, a multicentre study]". Zhonghua Nei Ke Za Zhi (in Chinese). 35 (1): 12–4. PMID 9275638.
- ^ Kitahata H, Nozaki J, Kawahito S, Tomino T, Oshita S (September 2008). "Low-dose sevoflurane inhalation enhances late cardioprotection from the anti-ulcer drug geranylgeranylacetone". Anesth. Analg. 107 (3): 755–61. doi:10.1213/ane.0b013e31817f0e61. PMID 18713879. S2CID 19387865.